Elisabetta Garibaldi

Aosta, 11100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Can Deep Learning-Based Auto-Contouring Software Achieve Accurate Pelvic Volume Delineation in Volumetric Image-Guided Radiotherapy for Prostate Cancer? A Preliminary Multicentric Analysis.

Can Deep Learning-Based Auto-Contouring Software Achieve Accurate Pelvic Volume Delineation in Volumetric Image-Guided Radiotherapy for Prostate Cancer? A Preliminary Multicentric Analysis.

Journal: Current oncology (Toronto, Ont.)

Published: April 16, 2025

Quality of life in low-risk prostate cancer under active surveillance or following radical treatments: the START cohort study.

Quality of life in low-risk prostate cancer under active surveillance or following radical treatments: the START cohort study.

Journal: Prostate cancer and prostatic diseases

Published: January 04, 2025

Prevention and management of radiotherapy-related toxicities in gynecological malignancies. Position paper on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology).

Prevention and management of radiotherapy-related toxicities in gynecological malignancies. Position paper on behalf of AIRO (Italian Association of Radiotherapy and Clinical Oncology).

Journal: La Radiologia medica

Published: March 07, 2024

Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer.

Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer.

Journal: JAMA network open

Published: October 17, 2023

Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors.

Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors.

Journal: Acta oncologica (Stockholm, Sweden)

Published: October 06, 2023

Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation.

Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: July 11, 2023

High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer.

High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer.

Journal: Frontiers in oncology

Published: May 06, 2022

Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation.

Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 14, 2022

Predictors of Patient-Reported Incontinence at Adjuvant/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and Radiotherapy.

Predictors of Patient-Reported Incontinence at Adjuvant/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and Radiotherapy.

Journal: Cancers

Published: May 07, 2021

Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study.

Acute patient-reported intestinal toxicity in whole pelvis IMRT for prostate cancer: Bowel dose-volume effect quantification in a multicentric cohort study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: November 07, 2020

CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth.

CAR T cells targeting tumor endothelial marker CLEC14A inhibit tumor growth.

Journal: JCI insight

Published: April 03, 2020

Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects.

Predictors of 2-Year Incidence of Patient-Reported Urinary Incontinence After Post-prostatectomy Radiotherapy: Evidence of Dose and Fractionation Effects.

Journal: Frontiers in oncology

Published: January 15, 2020

Showing 1-12 of 34

Last Updated: 09/26/2026